Clefts of the lip and/or palate (CLP) are immediately recognizable disruptions of normal facial structure. Although not a major cause of mortality in developed countries, CLP does cause considerable morbidity to affected children and imposes a substantial financial risk for families with a concomitant societal burden 1 . Individuals with CLP may experience problems with feeding, speaking, hearing and social integration that can be corrected to varying degrees by surgery, dental treatment, speech therapy and psychosocial intervention. CLP is aetiologically heterogeneous, and this has crucial implications for understanding the biology of facial development, how environmental risks interact with genetic factors and how we can incorporate known aetiologic variables to improve clinical care. Recent successes in genome-wide linkage and association studies have identified novel loci that are significantly associated with CLP [2] [3] [4] [5] [6] . Researchers are currently striving to identify the aetiologic variants at these novel loci to understand the developmental disturbances leading to CLP. This knowledge should eventually result in improved prevention, treatment and prognosis for individuals with these conditions. Development of the lip and palate is outlined in FIG. 1 . The common forms of CLP involve disruption of tissue planes above the lip, extending into the nares and/or the palate (hard and/or soft) (FIG. 2) . Fogh-Andersen and Fraser 7, 8 noted that clefts involving the anterior structures (lip and primary palate) could be separated on both genetic and embryological grounds from those involving only the secondary palate. Although there are many disruptions affecting the craniofacial complex, the overwhelming majority involve only the upper lip and/ or palate. Further, approximately 70% of cases of CLP occur as isolated entities with no other apparent cognitive or craniofacial structural abnormalities; this is commonly termed 'isolated, non-syndromic CLP' . Because the defects arise early in embryological development, have a complex aetiology (with both genetic and environmental contributions) and modest recurrence rates, it has proven difficult to identify specific aetiologic factors. A combination of epidemiologic, candidate gene and genome-wide studies, plus analysis of animal models, has recently provided deeper insights into the causes of non-syndromic CLP.
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With the advent of the genomics era, there have been major advances in the identification of causative genetic mutations underlying syndromic forms of CLP (see the OMIM website for further information). By contrast, there has been less progress in advancing our understanding of the genetic aetiology of non-syndromic CLP owing to its genetic heterogeneity, departure from Mendelian inheritance patterns, the limited availability and expense of genomic tools and the necessity for very large data sets. However, the recent development of innovative approaches to phenotyping and powerful, cost-effective genomic tools, together with extrapolation from studies of syndromic forms of CLP, have increased our understanding of non-syndromic CLP. Because of its particular challenges, in this Review we focus on nonsyndromic CLP and we summarize syndromic forms (which are genetically tractable) only briefly. We discuss important epidemiologic clues, environmental contributions, genetic architecture and issues of phenotyping, gene discovery and insights into molecular pathogenesis. We also speculate about the implications of these findings for estimating recurrence, finding new clinical associations building on advances in imaging and using large databases to examine long-term outcomes.
Challenges in studying CLP Epidemiology. CLP affects approximately 1 in 700 live births, with wide variability across geographic origin, racial and ethnic groups, as well as environmental exposures and socioeconomic status. In general, Asian and native American populations have the highest reported birth prevalence rates, which are often as high as 1 in 500. european-derived populations have intermediate prevalence rates at approximately 1 in 1,000, and Africanderived populations have the lowest prevalence rates at approximately 1 in 2,500. These observations suggest that the relative contribution of individual susceptibility genes may vary across different populations 6, 9, 10 . The frequency of CLP also differs by gender and laterality: there is a 2:1 male to female ratio for clefts involving the lip, approximately a 1:2 male to female ratio for clefts of the palate only and a 2:1 ratio of left to right sided clefts among unilateral cleft lip cases.
Historically, CLP has been divided into cleft palate only and cleft lip with or without cleft palate (CL/P) 7, 8 . However, recent epidemiologic data suggest that cleft lip only may have unique aetiologic features, including strong genetic associations, whereas some individuals with cleft palate only show evidence of subclinical cleft lip [11] [12] [13] [14] [15] . nevertheless, this broad sub-division of anatomical defects is consistent with the distinct developmental origins of the lip/primary palate versus the secondary palate. Furthermore, separate cellular and genetic aetiologies for CL/P and cleft palate only are consistent with the general observation that these two conditions do not segregate in the same family, although exceptions have been reported for families with aetiologic mutations in specific genes (for example, tumour protein p63 (TP63), msh homeobox 1 (MSX1), interferon regulatory factor 6 (IRF6) and fibroblast growth factor receptor 1 (FGFR1)) [16] [17] [18] [19] [20] . Approximately 70% of all cases of CL/P and 50% of cases of cleft palate only are considered to be non-syndromic [21] [22] [23] . The remaining cases are composed of a wide range of malformation syndromes, including over 500 Mendelian syndromes (see the OMIM website for further information) as well as those arising secondary to chromosomal or teratogenic Figure 1 | Development of the lip and palate. Schematic diagrams of the development of the lip and palate in humans. a | The developing frontonasal prominence, paired maxillary processes and paired mandibular processes surround the primitive oral cavity by the fourth week of embryonic development. b | By the fifth week, the nasal pits have formed, which leads to the formation of the paired medial and lateral nasal processes. c | The medial nasal processes have merged with the maxillary processes to form the upper lip and primary palate by the end of the sixth week. The lateral nasal processes form the nasal alae. Similarly, the mandibular processes fuse to form the lower jaw. d | During the sixth week of embryogenesis, the secondary palate develops as bilateral outgrowths from the maxillary processes, which grow vertically down the side of the tongue. e | Subsequently, the palatal shelves elevate to a horizontal position above the tongue, contact one another and commence fusion. f | Fusion of the palatal shelves ultimately divides the oronasal space into separate oral and nasal cavities. effects. These syndromic forms are more tractable to genetic analysis, and box 1 provides a summary of a subset of syndromes in which the underlying genetic mutation has been identified (see also supplementary information s1 ( . Moreover, CLP is known to be influenced by environmental risk factors 26, 27 ; consequently, a multifactorial model of inheritance is favoured in which genetic risk factors of small, individual impact may interact with environmental covariates 12 . These combined factors complicate genetic analysis of non-syndromic forms of CLP.
Accurate phenotyping is crucial to understanding both the epidemiology and aetiology of any congenital malformation because the power to detect effects is weakened when heterogeneous groups are treated as a single entity. Although clefts of the lip and palate show a range of phenotypic expression (FIG. 2) , they are generally defined as qualitative traits (that is, affected or unaffected). Dividing CLP in this simplistic way could potentially result in important information being lost. For example, different patterns of genome-wide linkage are observed when multiplex families are divided into subgroups depending on the overt CLP phenotypes present in affected individuals. This observation suggests that careful attention to phenotypes will be an important tool for furthering our understanding of the genetic heterogeneity underlying non-syndromic CLP 2 . Furthermore, numerous lines of evidence now suggest that the phenotypic spectrum of non-syndromic CLP is more complex than previously realized and should include a variety of subclinical phenotypic features observed in either an individual with CLP and/or their 'unaffected' relatives 28 .
Box 1 | Clefting syndromes in which the mutated gene has been identified
An expanded version of these data with a full reference list is provided as Supplementary information S1 (table) . ACTB, actin, β; BCOR, BCL6 corepressor; CDH1, cadherin 1; CHARGE, coloboma, heart defect, atresia choanae, retarded growth and development, genital abnormality, and ear abnormality; CHD7, chromodomain helicase DNA binding protein 7; CHRNG, cholinergic receptor, nicotinic, γ; CLP, clefts of the lip and/or palate; COL, collagen; DHCR, dehydrocholesterol reductase; DHODH, dihydroorotate dehydrogenase; EFNB1, ephrin-B1; ESCO2, establishment of cohesion 1 homologue 2; FGFR, fibroblast growth factor receptor; FLN, filamin; FOX, forkhead box; HYLS1, hydrolethalus syndrome 1; IRF6, interferon regulatory factor 6; KCNJ2, potassium inwardly-rectifying channel, subfamily J, member 2; MID1, midline 1 (Opitz/BBB syndrome); MLL2, myeloid/lymphoid or mixed-lineage leukaemia 2; NIPBL, Nipped-B homologue; OFD1, oral-facial-digital syndrome 1; PHF8, PHD finger protein 8; PQBP1, polyglutamine binding protein 1; PTCH1, patched 1; PVRL1, poliovirus receptor-related 1 (herpesvirus entry mediator C); SATB2, SATB homeobox 2; SHH, sonic hedgehog; SLC26A2, solute carrier family 26 (sulfate transporter), member 2; SIX3, SIX homeobox 3; SOX9, SRY (sex determining region Y)-box 9; TBX, T-box; TCOF1, Treacher Collins-Franceschetti syndrome 1; TFAP2A, transcription factor AP2α (activating enhancer binding protein 2α); TGFBR, transforming growth factor, β receptor; TGIF1, TGFB-induced factor homeobox 1; TP63, tumour protein p63; WNT3, wingless-type MMTV integration site family, member 3.
cleft lip ± cleft palate Autosomal-dominant developmental malformations, deafness and dystonia -ACTB Familial gastric cancer and CLP -CDH1 Craniofrontonasal -EFNB1 Roberts -ESCO2 Holoprosencephaly -GLI2 'Oro-facial-digital' -GLI3 Hydrolethalus -HYLS1 Van der Woude/popliteal pterygium -IRF6 X-linked mental retardation and CL/P -PHF8
Lip pit
An indentation and/or sinus tract in the lower lip that is usually located to one or both sides of the midline. Lip prints are visual impressions taken of the upper and lower lip that can indicate the presence of pits.
Orbicularis oris
The muscle surrounding the mouth.
subclinical phenotypes can include minor structural variants, including lip pits/prints 29 , dental anomalies 30 , defects of the orbicularis oris muscle 31, 32 , three-dimensional facial image measurement 28 , brain variants as assessed by MRI 33, 34 or by surrogate measures 35, 36 , and speech or cognitive differences such as velopharyngeal insufficiency, reading disability and IQ. Palatal subphenotypes have been less explored but also include bifid uvula, submucous cleft palate, the differentiation of clefts of the hard and soft palate and possibly ankyloglossia. In the future, our understanding of palatal subdivisions by phenotype and pathway will benefit from both human and mouse models 37, 38 . Defects of the orbicularis oris muscle show particular promise for enhancing the search for causative genetic variants and for contributing to clinical risk assessment 31, [39] [40] [41] [42] . Orbicularis oris defects can be assessed using high-resolution ultrasound of the upper lip (FIG. 3) . subclinical phenotyping therefore holds great promise to enhance the power of family studies and may lead to opportunities for translational research that is relevant for both clinical care of patients and clinical genetics as a science.
Gene discovery in non-syndromic CLP To date, genetic approaches to non-syndromic CLP have included: linkage analysis using large, multiplex families or smaller but inbred families, or analysis of affected relative pairs; association studies using case-parent trios or case-control samples; identification of chromosomal anomalies or microdeletions in cases; and direct sequencing of DnA samples from affected individuals. These methods can be applied to candidate genes or genome-wide strategies can be used. each approach has its own advantages and disadvantages, some of which will depend on the underlying genetic architecture of the disease, as well as the realities of economics and technology. We briefly summarize successes using a range of approaches, followed by further details on the results of recent genome-wide association (GWA) studies. Most studies of non-syndromic clefts to date have focused on CL/P rather than isolated cleft palate. This has been biased perhaps by the larger numbers of cases, easier ascertainment and less confusion from confounding syndromes. Future studies will need to address this gap and also the somewhat counter-intuitive observation that more mouse models are available for cleft palate than for cleft lip.
Candidate genes, chromosomal anomalies, linkage and sequencing. Candidate gene studies have been at the core of cleft research since Ardinger and colleagues 43 suggested a role for transforming growth factor-α (TGFA) variants in risk for non-syndromic CL/P. The identification of candidate genes has traditionally relied on gene expression and developmental analyses performed in model organisms, particularly the mouse, either to first identify the candidate genes or to provide biological plausibility for the association. More recently, extrapolation from the study of syndromic forms of CL/P has proven to be a useful adjunct to this approach. As with candidate gene studies of many complex disorders, rigorous confirmatory replication is not common, with only variants in interferon regulatory factor 6 (IRF6) yielding consistent evidence of association across multiple studies 12, [44] [45] [46] [47] (discussed further below). Analysis of chromosomal anomalies in patients has proven to be a productive route for the identification or confirmation of CL/P loci, with recent successes for fibroblast growth factor receptor 2 (FGFR2) 48 and SUMO1 (a member of the small ubiquitin-like modifier family) [49] [50] [51] . Candidate gene-based association studies and analyses of chromosomal anomalies have recently been reviewed in detail 27, 52 . 
Velopharyngeal insufficiency
Incomplete closing of the velopharyngeal sphincter (soft palate muscle) during speech.
There have been many attempts to use linkage analysis to identify regions of the genome that are likely to carry genes controlling pathogenesis of CLP, and the region surrounding the FOXE1 (forkhead box e1) gene reached genome-wide levels of significance with subsequent fine-mapping and replication 2, 53 . There have been several resequencing studies of candidate genes to identify specific variants that might underlie statistical associations with clefting, and the strongest current evidence is for mutations in MSX1 (REFs 18,54), FGFR1 and FGF8 (REF. 55 ), and bone morphogenetic protein 4 (BMP4) 39 . Whole-exome sequencing has recently been successful in identifying causative genetic variants for Mendelian traits 56, 57 , including Miller syndrome 58 (an autosomalrecessive syndrome that can include cleft palate) and Kabuki syndrome 59 (a dominant disorder than can include cleft palate), but is yet to be successful for complex and heterogeneous traits such as non-syndromic CLP.
Genome-wide association studies. As is now apparent for many common complex disorders, GWA studies have provided recent major advances in our understanding of genes and pathways that have a role in the aetiology of CLP. To date, there are three published GWA studies for CL/P using the case-control design [3] [4] [5] and one case-parent trio study from an international consortium that is part of GenevA (the gene environment association studies consortium) 6, 60 . These studies have mostly excluded cases with cleft palate only, based on likely aetiologic heterogeneity. Birnbaum and colleagues 3 confirmed the impact of IRF6, which had previously been identified in candidate gene studies 12, 44 , and discovered a new region on chromosome 8q24 that gave extremely strong evidence of association in their european case-control sample. Grant and colleagues independently confirmed that this 'gene desert' region on chromosome 8q24 was strongly associated with CL/P in a sample of european-American cases and controls 4 . Mangold and colleagues subsequently used an expanded data set from europe and identified additional loci at chromosomes 10q25 (with peak values closest to ventral anterior homeobox 1 (VAX1)) and 17q22 (with peak values closest to noggin (NOG)) that achieved genome-wide significance 5 . The GenevA Cleft Consortium study used caseparent trios from multiple populations and reconfirmed the IRF6 findings, as well as replicating the chromosome 8q24 and 10q25 (VAX1) associations 6 . Interestingly, in this consortium study, the level of statistical evidence from markers within chromosome 8q24 was much stronger among case-parent trios of european ancestry than among those of Asian ancestry, whereas the evidence for linkage and association for markers in IRF6 was much stronger in trios of Asian ancestry. This GenevA study identified at least two new loci (near MAFB and ABCA4) that were not previously associated with CL/P that reached genome-wide significance with stronger signals in Asian compared to european populations 6 . The signals and this population difference were replicated using independent families from multiple populations (see further details below).
These observations suggest not only that there are multiple genetic variants influencing risk of CL/P but also that some of these genes may be differentially tagged by polymorphic markers in a population-specific manner. For example, in the chromosome 8q24 region, the most significant snP (rs987525) showed similar patterns of over-transmission to the affected child but had a higher minor allele frequency among parents of european ancestry compared to parents of Asian ancestry (0.26 versus 0.07) 6 . In fact, the entire region of signal on chromosome 8q24 showed higher rates of heterozygosity among parents of european ancestry compared to those of Asian ancestry, which means that european trios would be far more informative than Asian trios for this region. Therefore, it may be more difficult to identify causal genetic variants in some populations compared to others. some putative causal genes or loci have been identified through polymorphic markers in most populations (for example, IRF6), whereas others (for example, 8q24, MAFB and ABCA4) seem to be more population-specific, which could reflect variable coverage by available marker panels or true allelic heterogeneity. True allelic heterogeneity, in which multiple mutations occurred on different background haplotypes, would make it much more difficult to identify causal genes through association studies. However, Dickson and colleagues 61 noted that there may be mixtures of multiple rare alleles on common haplotypes within a single causal gene for complex and heterogeneous disorders such as CLP.
Below, we provide a short summary of each of the genes confirmed or identified through GWA studies together with insights into the molecular pathogenesis derived from analysis of animal models. In TAbLE 1, we summarize genes with a confirmed role in non-syndromic CLP, those that seem likely to be involved and those that have been intensively studied but have less-convincing supporting data.
Insights into molecular pathogenesis
Although GWA studies will increase the number of CLP loci identified, the move from a GWA study signal to a causative variant will still be challenging. Animal models and gene expression data are powerful tools for identifying candidate genes for complex traits; importantly, they also contribute to our knowledge of normal facial development and the molecular pathogenesis of CLP. The mouse is the pre-eminent model organism for studies of this type, as facial development mirrors human craniofacial development, and mouse strains with high rates of CLP are available. A number of excellent reviews have described the cellular and molecular mechanisms underlying normal and abnormal development 62, 63 ; here we provide examples of how the mouse has influenced our understanding of the molecular pathogenesis of CLP in humans.
IRF6. Mutations in IRF6
were first identified as aetiologic in the autosomal-dominant van der Woude syndrome, which can include CL/P and/or cleft palate only along with dental anomalies and lip fistulas 19 . subsequent research showed that common alleles in IRF6 were associated with non-syndromic CL/P 44 . This association has been independently replicated in GWA studies as well as in many candidate gene studies [3] [4] [5] [6] 13, [44] [45] [46] [47] 64 ; some failures of replication were possibly due to population differences 65 . Recently, an approach that integrated the identification of cis-regulatory elements using sequence conservation across multiple species, analysis of animal models and biochemical analyses resulted in the identification of one specific sequence variant (rs642961, located within an enhancer ~10 kb upstream of the IRF6 transcription start site) that is significantly overtransmitted in non-syndromic cleft lip only 12 . Importantly, this apparent risk allele was found to disrupt a binding site for the transcription factor AP2α, which is mutated in the autosomal-dominant CLP disorder branchiooculo-facial syndrome 66 , therefore strongly suggesting that this snP is a contributory variant 12 .
A role of IRF6 in CLP is further supported by analysis of animal models. Recent research has shown that Irf6 mutant mice exhibit a hyper-proliferative epidermis that fails to undergo terminal differentiation, which leads to multiple epithelial adhesions that can occlude the oral cavity and result in cleft palate 67, 68 . These results demonstrated that IRF6 is a key determinant of the keratinocyte proliferation-differentiation switch, and subsequent research indicated that IRF6 also has a key role in the formation of oral periderm, spatiotemporal regulation of which is essential for ensuring appropriate palatal adhesion 69 . Recently, a combination of mouse genetics, gene expression analyses, chromatin immunoprecipitation studies and luciferase reporter assays has shown that IRF6 is a direct target of p63, which underlies several malformation syndromes that include CLP as a hallmark feature 16, 17 . p63 activates IRF6 transcription through the IRF6 enhancer element, variation within which increases susceptibility to cleft lip only 70 .
MAFB.
The MAFB gene encodes a basic leucine zipper transcription factor. Markers near MAFB achieved genome-wide significance in the GenevA Cleft Consortium study 6 , with trios of Asian descent providing much stronger statistical evidence than trios of european descent. In independent replication samples, 1,149 pedigrees of european ancestry showed evidence of linkage and association with a snP (rs13041247; p = 0.0007) located 260 bp from the snP yielding the strongest signal among Asian families (rs11696257; p = 0.0009 in 331 independent pedigrees). A missense mutation, H131Q, in MAFB was found in 3.5% of Filipinos with CL/P but only 0.7% of controls (p < 0.0001). This variant occurs in a region of strongly conserved sequence, suggesting that there may be a rare variant in MAFB that contributes to the observed signal in the GWA study. It is noteworthy that the gene-poor regions either side of MAFB include numerous binding sites for transcription factors that are known to have a role in palate development (including transcription factors in the MsX, IRF, sRY-box containing (sOX) and BTB and CnC homology (BACH) gene families). In the mouse, Mafb is highly expressed in the epithelium of the palatal shelves and in the medial edge epithelium during palatal fusion 6 . ABCA4. ABCA4 encodes an ATP-binding cassette transporter. Multiple markers in ABCA4 (within and 5′ to the transcribed region) gave evidence of linkage and association at the genome-wide significance level in the GenevA Cleft Consortium GWA study 6 , again with stronger evidence among Asian samples. Two of the snPs with the strongest signals were replicated in independent family samples, and one of these snPs (rs560426) gave a far stronger signal in Asian families (p = 0.0003 in 331 pedigrees) compared to european families (p = 0.005 in 1149 pedigrees). This difference in the strength of statistical evidence again raises the possibility of either an allele common to both groups but with differing frequencies, or multiple risk alleles At least one study with conservation/ compelling data and other supportive studies. § Multiple studies, no consensus or convincing meta-analysis. BMP4, bone morphogenetic protein 4; CLP, clefts of the lip and/or palate; CRISPLD2, cysteine-rich secretory protein LCCL domain containing 2; FGFR, fibroblast growth factor receptor; FOXE1, forkhead box E1 (thyroid transcription factor 2); GSTT1, glutathione S-transferase-θ1; GWA, genome-wide association; IRF6, interferon regulatory factor 6; L, linkage; LD, candidate gene association; M, mutation detection; MAFB, v-maf musculoaponeurotic fibrosarcoma oncogene homologue B; MSX1, msh homeobox 1; MTHFR, methylenetetrahydrofolate reductase (NAD(P)H); MYH9, myosin, heavy chain 9, non-muscle; PDGFC, platelet-derived growth factor C; PVRL1, poliovirus receptor-related 1 (herpesvirus entry mediator C); TGFA, transforming growth factor-α; TGFB3, transforming growth factor-β3; VAX1, ventral anterior homeobox 1.
Odds ratio
A measurement of association that is commonly used in case-control studies. It is defined as the odds of exposure to the susceptible genetic variant in individuals with disease compared with that in controls. If the odds ratio is significantly greater than one, the genetic variant is associated with the disease.
occurring on different haplotype backgrounds. ABCA4 is known to cause the autosomal-recessive retinal degenerative disease stargardt's disease, and sequencing of the 50 exons of ABCA4 in 190 CL/P cases identified 27 different missense mutations, many of which have been previously reported in stargardt's or other ocular disorders (see the OMIM website for details). As ABCA4 is surrounded by many other genes, the peak signal in ABCA4 may be a surrogate for aetiologic variants in another gene nearby. Furthermore, no Abca4 expression has been seen in mouse palatal shelves around the time of palatal fusion 6 .
VAX1. In the studies by Mangold et al. 5 and the GenevA Cleft Consortium 6 , markers in or near the VAX1 gene at chromosome 10q25 yielded evidence approaching genome-wide significance; the same two alleles of snPs in VAX1 (rs7078160 and rs4752028) were overrepresented in CL/P cases in both studies. VAX1 encodes a transcriptional regulator with a DnA-binding homeobox domain. Mouse knockouts for Vax1 develop cleft palate, and this gene is expressed widely in developing craniofacial structures 71 ; thus, variants in VAX1 itself are strong candidates for contributing to CLP.
WNT signalling.
Although not yet implicated by GWA studies, variants within WnT genes have been reported to be associated with non-syndromic CL/P 72 , and mutations in WNT3 underlie autosomal-recessive tetra-amelia with cleft lip and palate 73 . Although the evidence for the involvement of WnT signalling in non-syndromic CL/P is not strong, these findings have led to further analyses of genes in the WnT signalling pathway as candidates for normal development of the lip and palate. Targeted mutation of Wnt9b in mice leads to CLP, and the A/Wysn strain of mice, which have increased incidence of spontaneous CLP, have a retrotransposon inserted 6.6 kb downstream of the Wnt9b gene (a site known as the clf1 locus) 74 . These findings suggest that WnT9B has a key role in the development of the lip [74] [75] [76] . Further support for this hypothesis arises from the observation that canonical WnT signalling is activated during midfacial morphogenesis in mice 77 . Additionally, genetic inactivation of low density lipoprotein receptor-related protein 6 (Lrp6), a co-receptor of the WnT-β-catenin signalling pathway, causes CLP 78 . Intriguingly, Msx1 and Msx2 (see below) are downstream targets of this WnT-β-catenin signalling pathway during lip formation and fusion 78 .
MSX1 and BMP signalling. As in humans, loss-offunction mutations in the homeobox gene Msx1 result in cleft palate in mice 79 . Msx1 is a downstream target of BMP signalling in a number of embryonic tissues and Msx1 is necessary for expression of Bmp4 and/ or Bmp2 (REF. 80 ). In mice, loss-of-function of type I BMP receptor (Bmpr1a) in the craniofacial primordia resulted in CL/P, whereas deficiency of Bmp4 resulted in cleft lip only 81 ; this shows that BMP signalling has distinct functions in development of the lip versus the secondary palate. In the context of Bmp4 deficiency, all Bmp4 mutant embryos exhibited bilateral cleft lip at embryonic day 12 (e12), but only 22% still displayed cleft lip at e14, which suggests that there is some kind of in utero repair mechanism 81 .These observations parallel the findings that mutations in BMP4 may underlie a subset of cases of subepithelial, microform and overt cleft lip in humans 39 .
Environment and gene-environment interaction
The identification of environmental components of clefting and studies of gene by environment interaction require large (ideally prospective) cohort studies and access to genetic material to be optimally effective. Although a few such resources are available (in Denmark, norway, and the united states) 11, 14, 15 , they are still primarily in the analysis phase. nonetheless, there are a few studies that have begun to provide data on environmental risks. Because the environment is more malleable, the identification of environmental risks, particularly if they can be personalized with genetic covariates, provides the best short-term opportunities to be applied to prevention.
Maternal smoking has been associated repeatedly with increased risk of CLP, and meta-analysis strongly supports an overall odds ratio (OR) for having CLP of ~1.3 among offspring of mothers who smoke [82] [83] [84] . The increased risk resulting from exposure to maternal smoking during the peri-conceptual period raises the possibility that genes in certain metabolic pathways may have a role in the development of CLP. specifically, markers in the glutathione s-transferase-θ1 (GSTT1) or nitric oxide synthase 3 (NOS3) genes appear to influence risk of CL/P in the presence of maternal smoking 83, [85] [86] [87] . The GSTT1 markers are gene deletion variants, which suggests that deficiencies in detoxification pathways may underlie some of this susceptibility. smoking has also been recently associated with a joint risk with variants in IRF6, and the same study reported interactions between multivitamins and IRF6 variants 88 . These findings provide evidence that gene-environment interactions are important in CLP. In addition, some specific teratogens 26, 27, 89 -for example, valproic acid -have yielded evidence of association with cleft palate 90 . exposure to maternal alcohol consumption has also been suggested as a risk factor, but the evidence has been more inconsistent 27 . studies also suggest that 'binge' drinking patterns (high doses of alcohol in short periods of time) increase risk 91 , and this is supported by associations with variation in the ADH1C alcohol dehydrogenase gene 92 . However, these links to alcohol consumption remain to be confirmed. nutritional factors, such as folate deficiency, have also been suggested to influence risk of CL/P, based on both observational studies and interventional trials using folate supplementation to prevent recurrences of CL/P in families 93 . However, the studies of vitamin supplementation with folate remain controversial 1, 94 and recent studies of levels of folate receptor antibodies did not find an association with CL/P 95 . Furthermore, food fortification programmes using folic acid have shown
Mendelian randomization
The random assignment of alleles from parents to offspring that occurs during gamete formation. It is the underlying concept of a method to genetically stratify individuals in a large population sample and then to evaluate phenotypic differences based on a pre-specified genotype.
detectable decreases in the rates of clefting in some 96, 97 but not all 98, 99 studies. In the future, other nutrient and micronutrient studies will need to be expanded to look for evidence of effects. For example, there are some data to support roles for zinc deficiency in risk of oral clefts in populations in which zinc status is highly compromised 100 , for cholesterol deficiency in facial clefting 101 , and for multivitamins in general in cleft prevention 97 . Besides nutrients and toxins, other environmental exposures have been, and should continue to be, assessed for possible roles in clefting. These exposures include hyperthermia 102 , stress, maternal obesity, occupational exposures, ionizing radiation and infection 10 . Pregnancy planning has been shown to have a protective effect, and the basis of this observation needs to be more deeply explored 103 . nonetheless, there is no consensus yet on the harmful effects of these factors, and prospective cohort studies large enough to measure effects on a relatively rare disorder such as clefting may be required. A particular challenge will be to determine the specificity of the role of an exposure in contributing to clefting, as many exposures will have both identifiable and unidentifiable coincident risks. Analytic approaches such as Mendelian randomization will be helpful in making these determinations 104 . A new, developing database (FaceBase) is providing a common source for human and animal model data on genes and gene expression relevant to facial clefting.
Integrating evidence into clinical care
Despite the recent identification of genes that are likely to influence the risk of non-syndromic CLP, these results have yet to have any direct impact on genetic counselling or clinical management. Improved epidemiologic information does, however, allow for better point estimates for familial recurrence risks 14 . Furthermore, it seems likely that genotypic information for apparent risk alleles associated with higher risk of oral clefts could be useful in clinical assessment (once we have a better definition of the full number of causal genes and their potential interactions with one another and with environmental risk factors). The next critical phase of statistical analyses will be to examine the heterogeneity underlying the aetiology of oral clefts and to investigate the gene-gene and gene-environment interactions that control risk. A range of study designs will be needed to achieve this level of documentation, including family studies, case-control studies and eventually prospective cohort data. Importantly, incorporating information from subclinical phenotypes, such as orbicularis oris defects or dental anomalies, may also allow us to identify aetiologically homogeneous subgroups of cleft cases, and thus should enhance family studies and estimates of recurrence risk 42 . new array-based copy-number-variant analysis and whole-exome or even whole-genome re sequencing could also provide future opportunities for improved molecular diagnostics, and the continually improving ultrasound analysis of the fetus may allow earlier identification of the presence and severity of cleft type before birth.
Gene expression in time and space. Global approaches to expression analyses of genes in craniofacial structures have already provided a broad view of gene expression. For example, the Craniofacial and Oral Gene expression network (COGene) project provides public web access to human gene expression data for 24 craniofacial-specific human tissues isolated from day 26 to day 60 human embryos. In zebrafish, mRnA sequencing and microRnA analysis have been informative for understanding palate development, so it would be useful to build on this knowledge 105 . similarly, the ability to analyse tissues in their correct three-dimensional orientation is central to understanding biological processes, particularly when tissues undergo a complex and intricate series of movements relative to each other, as occurs in the developing craniofacial region. The mapping of gene and protein expression patterns within these complex shapes can provide important clues about their biological functions and also indicates which genes and/or proteins may interact with one another. The expression of genes relative to each other in both time and space can be visually represented using optical projection tomography (OPT) 106 , and an atlas of craniofacial gene expression patterns is available online in the eMAGe database.
Cis-regulatory element identification. Much of the genetic variation underlying complex disorders (such as non-syndromic CLP) is likely to occur in regulatory elements outside coding sequences of genes. These elements are challenging to identify as they often regulate genes across substantial genomic distances. Although evolutionary sequence conservation can facilitate the discovery of regulatory elements, this technique does not predict their spatiotemporal pattern of activity in vivo 107 . Recently, chromatin immunoprecipitation followed by next-generation sequencing analysis (ChIP-seq) for the enhancer-associated protein p300 has been demonstrated to be a highly sensitive method to accurately identify enhancer elements and their associated activities 108 . Clearly, detailed mapping of regulatory elements will provide additional (and functionally relevant) targets for sequence analysis, particularly where they fall within regions of the genome implicated by GWA studies or other approaches. The power of integrating association studies in well-characterized patient populations with identification of cis-regulatory elements, analysis of animal models and biochemical analyses is amply illustrated by the example of IRF6 noted above.
Wider implications. Biological roles outside the craniofacial complex are known for some of the candidate genes associated with CLP, increasing the importance of CLP gene-finding endeavours. One recent publication on a small data set suggests a role for IRF6 in wound healing, at least in the autosomal-dominant van der Woude syndrome 109 . Long-term outcomes of individuals born with clefts may include risks for higher overall mortality rates, mental health problems 110 , a higher risk of cancer (particularly breast cancer) in affected individuals 111 and their family members 112 and alterations in child bearing patterns 113 . Identifying long-term adverse outcomes (for example, cancer and psychiatric disorders) that are seemingly unrelated to a common birth defect may eventually result in decreasing an individual's lifelong health burden by recognizing risks at their early, presymptomatic stages. studies into the aetiology of clefts may well enhance our understanding of other common, complex traits and allow us to move beyond the attitude that CLP is only a structural birth defect, but instead is a lifelong disorder for which therapies and prevention can promise a fuller and healthier lifespan.
Future approaches. Future advances in our understanding of the molecular pathogenesis of CLP will require strategies that increasingly integrate genetic analysis of precisely phenotyped cohorts of patients, global approaches for the identification and ranking of candidate genes, and improved methods for delineating and analysing functional elements controlling gene expression. Integration of genetic and environmental risk using epigenetics, systems biology, gene expression and epidemiology will all be required to generate a synthesis that will more completely characterize aetiologies, as well as provide access to better clinical care and prevention.
